| 000 | 00868cam a2200169 4500500 | ||
|---|---|---|---|
| 005 | 20250121081815.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aBresteau, Clément _eauthor |
| 700 | 1 | 0 |
_a Uzzan, Mathieu _eauthor |
| 245 | 0 | 0 | _aIBD and infliximab: Is this the end of proactive therapeutic drug monitoring? |
| 260 | _c2022. | ||
| 500 | _a78 | ||
| 520 | _aSyversen SW, Jørgensen KK, Goll GL, et al. Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients with Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial. JAMA 2021; 325 (17): 1744–54 | ||
| 786 | 0 | _nHépato-Gastro & Oncologie Digestive | 29 | 2 | 2022-02-01 | p. 251-254 | 2115-3310 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/journal-hepato-gastro-oncologie-digestive-2022-2-page-251?lang=en&redirect-ssocas=7080 |
| 999 |
_c498997 _d498997 |
||